Risk of Sepsis-Induced Coagulopathy Due to SARS CoV-2 in Pregnant Patients

    Manuel Morales Ortíz, Luciano Remião Guerra
    Studysummary In this study, 86% of pregnant women with SARS-CoV-2 received timely thromboprophylaxis based on their sepsis-induced coagulopathy scores, with most scoring between one and two.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on revistacunori.com →
    Discuss this study in the Community →